Comparative analysis of cell therapy infusion workflows at clinical sites

Delivering externally manufactured cell and gene therapy products to patients: perspectives from the academic center experience

“…Analyses from more specific aspects of cell therapy are providing additional insight as well. In a study comparing cell therapy infusion workflows, the study group found that inter-institutional variability in SOPs likely affected the efficiency of workflows [5]. This finding suggests that additional guidance and harmonization would accelerate the implementation of new cell therapy trials.…”